Cas:54043-71-9 2,2-Dimethylbutanedioic acid 4-methyl ester manufacturer & supplier

We serve Chemical Name:2,2-Dimethylbutanedioic acid 4-methyl ester CAS:54043-71-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,2-Dimethylbutanedioic acid 4-methyl ester

Chemical Name:2,2-Dimethylbutanedioic acid 4-methyl ester
CAS.NO:54043-71-9
Synonyms:4-methoxy-2,2-dimethyl-4-oxobutanoic acid;2,2-Dimethylbutanedioic acid 4-methyl ester
Molecular Formula:C7H12O4
Molecular Weight:160.16800
HS Code:2918990090

Physical and Chemical Properties:
Melting point:49-50 ºC
Boiling point:256.2ºC at 760 mmHg
Density:1.126g/cm3
Index of Refraction:1.444
PSA:63.60000
Exact Mass:160.07400
LogP:0.66030

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-methoxy-2,2-dimethyl-4-oxobutanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2-Dimethylbutanedioic acid 4-methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methoxy-2,2-dimethyl-4-oxobutanoic acid Use and application,2,2-Dimethylbutanedioic acid 4-methyl ester technical grade,usp/ep/jp grade.


Related News: ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 2,2-Dimethylbutanedioic acid 4-methyl ester manufacturer British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. 2,2-Dimethylbutanedioic acid 4-methyl ester supplier ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 2,2-Dimethylbutanedioic acid 4-methyl ester vendor The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 2,2-Dimethylbutanedioic acid 4-methyl ester factory British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.